Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046027
Filing Date
2021-07-08
Accepted
2021-07-08 18:14:53
Documents
1
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13520
  Complete submission text file 0001209191-21-046027.txt   14869
Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 RIDGE MCINTIRE ROAD, SUITE 350 CHARLOTTESVILLE VA 22903
Business Address
Hardie Robert D. (Reporting) CIK: 0001804350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 211081194